Sign Up to like & get
recommendations!
1
Published in 2023 at "Cancer Management and Research"
DOI: 10.2147/cmar.s341468
Abstract: Abstract Esophagogastric cancers are aggressive malignancies, with poor prognosis despite current standard-of-care therapies. PD-1 inhibitors are a newer class of antitumor agents with the potential to improve outcomes among appropriately selected patients. This review provides…
read more here.
Keywords:
treatment esophagogastric;
role;
role inhibitors;
inhibitors treatment ... See more keywords